COX-2 expression and effects of celecoxib in addition to standard chemotherapy in advanced non-small cell lung cancer

Abstract

In this subgroup analysis of patients with advanced NSCLC treated within the context of a randomized trial, we could not detect any interaction effect of COX-2 expression in tumor or stromal cells and the outcome of celecoxib treatment in addition to standard chemotherapy.